Pharma Business - April 2, 2015
Biosimilar Drug a Hit in Norway
A biosimilar of Merck’s popular arthritis drug Remicade is going for a discount of nearly 70 percent of the branded price in Norway, upsetting conventional wisdom and competitors, according to a FiercePharma article. Finnish drug company Orion Oyj, which licenses the biosimilar Remsima from South Korea’s Celltrion, began with a 39 percent discount for the […]
